Thanks @Phaedrus. I re-read the 31 January ASX announcement on...

Thanks @Phaedrus. I re-read the 31 January ASX announcement on the Dec qtr and ongoing business activity, and focusing on the first 3 bullet points under the GVHD heading, (rather than what some would call tea leaves), I read clearly about the type of data being generated by the company, and the purpose for which they were meant to demonstrate - in preparation for the in-person meeting http://announcements.asx.com.au/asxpdf/20240131/pdf/05zxzt40kgg289.pdf that took place later in the quarter. The latter led to the FDA communicating its latest, positive stance, which was confirmed in formal minutes and announced to the market by the company in a more brief manner in late March.